Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting AMPK with Irisin: Implications for metabolic disorders, cardiovascular health, and inflammatory conditions - A systematic review.
Laurindo LF, Rodrigues VD, Laurindo LF, Cherain LMA, de Lima EP, Boaro BL, da Silva Camarinha Oliveira J, Chagas EFB, Catharin VCS, Dos Santos Haber JF, Dos Santos Bueno PC, Direito R, Barbalho SM. Laurindo LF, et al. Life Sci. 2024 Nov 10;360:123230. doi: 10.1016/j.lfs.2024.123230. Online ahead of print. Life Sci. 2024. PMID: 39532260 Free article. Review.
Exploring the logic and conducting a comprehensive evaluation of AdipoRon-based adiponectin replacement therapy against hormone-related cancers-a systematic review.
Laurindo LF, Sosin AF, Lamas CB, de Alvares Goulart R, Dos Santos Haber JF, Detregiachi CRP, Barbalho SM. Laurindo LF, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2067-2082. doi: 10.1007/s00210-023-02792-z. Epub 2023 Oct 21. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37864589 Review.
Unraveling the rationale and conducting a comprehensive assessment of AdipoRon (adiponectin receptor agonist) as a candidate drug for diabetic nephropathy and cardiomyopathy prevention and intervention-a systematic review.
Laurindo LF, Laurindo LF, Rodrigues VD, Catharin VMCS, Simili OAG, Barboza GO, Catharin VCS, Sloan KP, Barbalho SM. Laurindo LF, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug 13. doi: 10.1007/s00210-024-03362-7. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39136737 Review.
Exploring the Logic and Conducting a Comprehensive Evaluation of the Adiponectin Receptor Agonists AdipoRon and AdipoAI's Impacts on Bone Metabolism and Repair-A Systematic Review.
Laurindo LF, Minniti G, Rodrigues VD, Laurindo LF, Catharin VMCS, Chagas EFB, Anjos VD, de Castro MVM, Baldi Júnior E, Sanches RCF, Méndez-Sánchez N, Barbalho SM. Laurindo LF, et al. Curr Med Chem. 2024 Aug 28. doi: 10.2174/0109298673308301240821052742. Online ahead of print. Curr Med Chem. 2024. PMID: 39206478
Exploring the benefits of astaxanthin as a functional food ingredient: Its effects on oxidative stress and reproductive outcomes in women with PCOS - A systematic review and single-arm meta-analysis of randomized clinical trials.
Rodrigues VD, Boaro BL, Laurindo LF, Chagas EFB, de Lima EP, Laurindo LF, Barbalho SM. Rodrigues VD, et al. Among authors: laurindo lf. Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep 13. doi: 10.1007/s00210-024-03432-w. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39269488 Review.
42 results